CA2067816A1 - Antagonistes des recepteurs muscariniques - Google Patents
Antagonistes des recepteurs muscariniquesInfo
- Publication number
- CA2067816A1 CA2067816A1 CA2067816A CA2067816A CA2067816A1 CA 2067816 A1 CA2067816 A1 CA 2067816A1 CA 2067816 A CA2067816 A CA 2067816A CA 2067816 A CA2067816 A CA 2067816A CA 2067816 A1 CA2067816 A1 CA 2067816A1
- Authority
- CA
- Canada
- Prior art keywords
- pct
- compounds
- date jun
- sec
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 abstract 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 abstract 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 230000003551 muscarinic effect Effects 0.000 abstract 2
- 210000002460 smooth muscle Anatomy 0.000 abstract 2
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004899 motility Effects 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
- 210000003437 trachea Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898928041A GB8928041D0 (en) | 1989-12-12 | 1989-12-12 | Muscarinic receptor antagonists |
| GB8928041.6 | 1989-12-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2067816A1 true CA2067816A1 (fr) | 1991-06-13 |
| CA2067816C CA2067816C (fr) | 1997-03-25 |
Family
ID=10667812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002067816A Expired - Fee Related CA2067816C (fr) | 1989-12-12 | 1990-11-28 | Antagonistes des recepteurs muscariniques |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5281601A (fr) |
| EP (1) | EP0505377B1 (fr) |
| JP (1) | JPH0684370B2 (fr) |
| AT (1) | ATE132488T1 (fr) |
| CA (1) | CA2067816C (fr) |
| DE (1) | DE69024663T2 (fr) |
| DK (1) | DK0505377T3 (fr) |
| ES (1) | ES2082013T3 (fr) |
| FI (1) | FI104719B (fr) |
| GB (1) | GB8928041D0 (fr) |
| GR (1) | GR3019036T3 (fr) |
| IE (1) | IE70733B1 (fr) |
| PT (1) | PT96143B (fr) |
| WO (1) | WO1991009015A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| RU2230060C2 (ru) | 2000-01-20 | 2004-06-10 | Эйсай Ко., Лтд. | Соединения, фармацевтическая композиция, способ предотвращения гибели нервных клеток, способ профилактики |
| NZ537584A (en) | 2002-07-08 | 2006-07-28 | Ranbaxy Lab Ltd | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| DE60226906D1 (de) * | 2002-07-31 | 2008-07-10 | Ranbaxy Lab Ltd | 3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen |
| EP1545508A4 (fr) * | 2002-08-09 | 2009-11-25 | Ranbaxy Lab Ltd | Derives d'azabicyclo ¬3.1.0 hexane 3,6-disubstitues, utiles en tant qu'agonistes de recepteurs muscariniques |
| JP2006501236A (ja) * | 2002-08-23 | 2006-01-12 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性レセプター拮抗薬としてのフルオロおよびスルホニルアミノ含有３，６−二置換アザビシクロ（３．１．０）ヘキサン誘導体 |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| ATE400553T1 (de) * | 2002-12-10 | 2008-07-15 | Ranbaxy Lab Ltd | 3,6-disubstituierte azabicyclo 3.1.0 - hexanderivative als antagonisten des muscarinrezeptors |
| US7465751B2 (en) * | 2002-12-23 | 2008-12-16 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| AU2002347553A1 (en) * | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | Flavaxate derivatives as muscarinic receptor antagonists |
| US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| EP1618091A1 (fr) * | 2003-04-09 | 2006-01-25 | Ranbaxy Laboratories, Ltd. | Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques |
| EA009059B1 (ru) * | 2003-04-10 | 2007-10-26 | Рэнбакси Лабораториз Лимитед | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора |
| EP1615887A1 (fr) | 2003-04-10 | 2006-01-18 | Ranbaxy Laboratories, Ltd. | Derives d'azabicyclo hexanes en tant qu'antagonistes des recepteurs muscariniques |
| EA009387B1 (ru) * | 2003-04-11 | 2007-12-28 | Рэнбакси Лабораториз Лимитед | Азабициклические производные в качестве антагонистов мускаринового рецептора |
| US7368463B2 (en) * | 2003-07-11 | 2008-05-06 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
| US7234991B2 (en) * | 2004-05-10 | 2007-06-26 | Firecode Ltd. | Moving toy |
| US20080319002A1 (en) * | 2004-06-16 | 2008-12-25 | Ranbaxy Laboratories Limited | Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists |
| EP1781607A2 (fr) * | 2004-08-19 | 2007-05-09 | Ranbaxy Laboratories Limited | Derives de pyrrolidine utilises en tant qu'antagonistes des recepteurs muscariniques |
| US20080280883A1 (en) * | 2004-09-24 | 2008-11-13 | Mohammad Salman | Muscarinic Receptor Antagonists |
| EP1797040A1 (fr) * | 2004-09-29 | 2007-06-20 | Ranbaxy Laboratories Limited | Antagonistes de recepteurs muscariniques |
| US20100016400A1 (en) * | 2004-11-19 | 2010-01-21 | Naresh Kumar | Azabicyclic muscarinic receptor antagonists |
| EP1828126A1 (fr) * | 2004-12-15 | 2007-09-05 | Ranbaxy Laboratories Limited | Sels d'addition d'acide d'antagonistes du recepteur muscarinique |
| EP1888525A1 (fr) * | 2005-05-03 | 2008-02-20 | Ranbaxy Laboratories Limited | Derives d'azabicyclo [3.1.0]hexane 3,6-disubstitues utilises comme antagonistes du recepteur muscarinique |
| JP2009512676A (ja) | 2005-10-19 | 2009-03-26 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性受容体アンタゴニストの医薬組成物 |
| US20090010923A1 (en) * | 2007-04-24 | 2009-01-08 | University Of Maryland, Baltimore | Treatment of cancer with anti-muscarinic receptor agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE632403A (fr) * | 1962-05-17 | 1900-01-01 | ||
| GB1455687A (en) * | 1972-12-28 | 1976-11-17 | Aspro Nicholas Ltd | Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines |
| DE3835291A1 (de) * | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
-
1989
- 1989-11-28 US US07/859,489 patent/US5281601A/en not_active Expired - Fee Related
- 1989-12-12 GB GB898928041A patent/GB8928041D0/en active Pending
-
1990
- 1990-11-28 JP JP2515785A patent/JPH0684370B2/ja not_active Expired - Fee Related
- 1990-11-28 CA CA002067816A patent/CA2067816C/fr not_active Expired - Fee Related
- 1990-11-28 DE DE69024663T patent/DE69024663T2/de not_active Expired - Fee Related
- 1990-11-28 EP EP90917074A patent/EP0505377B1/fr not_active Expired - Lifetime
- 1990-11-28 ES ES90917074T patent/ES2082013T3/es not_active Expired - Lifetime
- 1990-11-28 AT AT90917074T patent/ATE132488T1/de not_active IP Right Cessation
- 1990-11-28 DK DK90917074.8T patent/DK0505377T3/da active
- 1990-11-28 WO PCT/EP1990/002042 patent/WO1991009015A1/fr active IP Right Grant
- 1990-12-10 PT PT96143A patent/PT96143B/pt not_active IP Right Cessation
- 1990-12-11 IE IE446290A patent/IE70733B1/en not_active IP Right Cessation
-
1992
- 1992-05-22 FI FI922344A patent/FI104719B/fi active
-
1996
- 1996-02-21 GR GR960400439T patent/GR3019036T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69024663D1 (de) | 1996-02-15 |
| PT96143B (pt) | 1997-05-28 |
| ES2082013T3 (es) | 1996-03-16 |
| WO1991009015A1 (fr) | 1991-06-27 |
| CA2067816C (fr) | 1997-03-25 |
| IE70733B1 (en) | 1996-12-11 |
| EP0505377A1 (fr) | 1992-09-30 |
| GB8928041D0 (en) | 1990-02-14 |
| GR3019036T3 (en) | 1996-05-31 |
| JPH0684370B2 (ja) | 1994-10-26 |
| FI922344A0 (fi) | 1992-05-22 |
| US5281601A (en) | 1994-01-25 |
| EP0505377B1 (fr) | 1996-01-03 |
| DK0505377T3 (da) | 1996-02-05 |
| JPH05501555A (ja) | 1993-03-25 |
| FI922344A (fi) | 1992-05-22 |
| FI104719B (fi) | 2000-03-31 |
| IE904462A1 (en) | 1991-06-19 |
| DE69024663T2 (de) | 1996-05-15 |
| ATE132488T1 (de) | 1996-01-15 |
| PT96143A (pt) | 1991-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2067816A1 (fr) | Antagonistes des recepteurs muscariniques | |
| DK0487071T3 (da) | Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse | |
| DE68910210D1 (de) | (1-Hydroxy-2-piperidinylalkyl)-2-indolon, 2-quinolinon, 2-benzo[b]azepinon, 2-benzimidazolon und 2-quinazolinon-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung. | |
| DK0518558T3 (da) | 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika | |
| HUT41713A (en) | Process for production of //arol-cyclobutyl/ alkyl/-amins and medical preparatives containing thereof | |
| KR900011728A (ko) | 5-리폭시게나제 억제제로서의 치환된 인돌, 벤조푸란 및 벤조티오펜 유도체 | |
| Marxer et al. | Spiro piperidines. I. Synthesis of spiro [isobenzofuran-1 (3H), 4'-piperidines] and spiro [isobenzofuran-1 (3H), 3'-piperidines] | |
| FI922835A (fi) | Menetelmä terapeuttisesti aktiivisten piperidiinijohdannaisten valmistamiseksi | |
| GR81183B (en) | (3-aryl-2,3-dihydrobenzofuran-3-yl) alkylamines, process for their preparation and their use as medicaments | |
| ATA226688A (de) | Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE47391T1 (de) | Neue aromatische verbindungen, ihre herstellung und verwendung. | |
| US6127379A (en) | Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists | |
| RU2001102052A (ru) | Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата | |
| HUT43612A (en) | Process for production of new derivatives of peneme and medical preparatives containing thereof | |
| AU630079B2 (en) | New labdane derivatives, a process for their preparation, and their use as medicaments | |
| JPS5695188A (en) | Theophyllin derivative and its production | |
| EP0679649A4 (fr) | Derive de 2,3-dihydrobenzofuranne. | |
| DK0429751T3 (da) | Substituerede 3-aminosydnoniminer, fremgangsmåde til deres fremstilling og deres anvendelse | |
| NO983452L (no) | FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer) | |
| DK0462150T3 (da) | Aryloxyalkylaminer, deres fremstilling og lægemidler indeholdende dem | |
| RU93005335A (ru) | Антогонисты рецептора тахикинина, изохинолины и способ их получения | |
| RU97119859A (ru) | Производные азациклоалкана, их получение и применение в терапии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |